Kejing Ying

823 total citations
28 papers, 566 citations indexed

About

Kejing Ying is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Kejing Ying has authored 28 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Kejing Ying's work include Advanced Chemical Sensor Technologies (5 papers), IgG4-Related and Inflammatory Diseases (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Kejing Ying is often cited by papers focused on Advanced Chemical Sensor Technologies (5 papers), IgG4-Related and Inflammatory Diseases (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Kejing Ying collaborates with scholars based in China and United States. Kejing Ying's co-authors include Enguo Chen, Ping Wang, Weimin Zhang, Xing Chen, Chen-Huan Yu, Lijun Feng, Jian Hua, Jing Shen, Yanjie Hu and Liangliang Dong and has published in prestigious journals such as Cancer, Food Research International and Medicine.

In The Last Decade

Kejing Ying

23 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kejing Ying China 11 243 174 120 94 68 28 566
Márcia Monteiro Portugal 10 107 0.4× 356 2.0× 108 0.9× 8 0.1× 24 0.4× 12 522
Mamatha Serasanambati United States 6 50 0.2× 88 0.5× 21 0.2× 14 0.1× 10 0.1× 13 267
Heinric Williams United States 10 50 0.2× 284 1.6× 29 0.2× 7 0.1× 109 1.6× 25 492
Ruizhi Li China 16 74 0.3× 169 1.0× 17 0.1× 10 0.1× 61 0.9× 44 637
Mei Lin China 15 49 0.2× 451 2.6× 66 0.6× 19 0.2× 35 0.5× 32 723
Wenjie Zheng China 14 106 0.4× 245 1.4× 59 0.5× 18 0.2× 15 0.2× 42 526
Xiaoling Zang China 11 130 0.5× 247 1.4× 76 0.6× 7 0.1× 15 0.2× 23 457
Yadong Lu China 13 50 0.2× 155 0.9× 29 0.2× 8 0.1× 35 0.5× 16 449

Countries citing papers authored by Kejing Ying

Since Specialization
Citations

This map shows the geographic impact of Kejing Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kejing Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kejing Ying more than expected).

Fields of papers citing papers by Kejing Ying

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kejing Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kejing Ying. The network helps show where Kejing Ying may publish in the future.

Co-authorship network of co-authors of Kejing Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Kejing Ying. A scholar is included among the top collaborators of Kejing Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kejing Ying. Kejing Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Shan, Qiang Yin, Jisong Zhang, et al.. (2025). To Evaluate the Diagnostic Performance of Rapid on-Site Evaluation (ROSE) in Combination with Endobronchial Ultrasound (EBUS) for Pulmonary Lesions. International Journal of General Medicine. Volume 18. 2237–2245. 1 indexed citations
2.
Li, Yeping, et al.. (2023). GDF15 affects venous thrombosis by promoting EndMT through smad2/p-smad2 pathway. Thrombosis Journal. 21(1). 98–98. 3 indexed citations
3.
He, Lulu, et al.. (2021). Exosomal lncRNA SCIRT/miR-665 Transferring Promotes Lung Cancer Cell Metastasis through the Inhibition of HEYL. Journal of Oncology. 2021. 1–13. 35 indexed citations
4.
Ma, Guofeng, et al.. (2021). Non-surgical management of an abrupt cavitation and large oval-shaped lung abscess secondary to acute thromboembolic pulmonary infarction: a case report. Journal of International Medical Research. 49(8). 3619092610–3619092610.
5.
Dong, Liangliang, et al.. (2021). Immunoglobulin G4-related disease: case report and literature review. Immunologic Research. 69(5). 415–421. 4 indexed citations
6.
Luo, Zhuanbo, Chao Cao, Ning Xu, & Kejing Ying. (2020). Classic biphasic pulmonary blastoma: a case report and review of the literature. Journal of International Medical Research. 48(10). 1220761946–1220761946. 8 indexed citations
7.
Zhou, Yong, Wenjing Ruan, Joy Q. Jin, et al.. (2019). Pulmonary vascular involvement of IgG4-related disease. Medicine. 98(6). e14437–e14437. 10 indexed citations
8.
Dong, Liangliang, et al.. (2015). Malignant glomus tumor of the lung with multiorgan metastases: case report and literature review. OncoTargets and Therapy. 1909–1909. 24 indexed citations
9.
Ying, Kejing, et al.. (2015). Diarrhea as initial manifestation of pulmonary artery intimal sarcoma: a case report and literature review. OncoTargets and Therapy. 8. 2651–2651. 3 indexed citations
10.
Wu, Xiaohong, Liangliang Dong, Ruifeng Zhang, Kejing Ying, & Huahao Shen. (2014). Transgelin overexpression in lung adenocarcinoma is associated with tumor progression. International Journal of Molecular Medicine. 34(2). 585–591. 30 indexed citations
11.
Wu, Ye, Yanjie Hu, Ruifeng Zhang, & Kejing Ying. (2014). Diagnostic value of the soluble triggering receptor expressed on myeloid cells‐1 in lower respiratory tract infections: A meta‐analysis. Respirology. 19(4). 501–507. 15 indexed citations
12.
Wang, Cheng, et al.. (2012). Differential proteome profiling of pleural effusions from lung cancer and benign inflammatory disease patients. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1824(4). 692–700. 46 indexed citations
13.
Ying, Kejing, et al.. (2012). Urticaria as the initial presentation of early stage bronchioloalveolar carcinoma: a case report.. PubMed. 125(11). 2065–6. 1 indexed citations
14.
Ying, Kejing, et al.. (2011). A case study of imported pulmonary coccidioidomycosis. Journal of Zhejiang University SCIENCE B. 12(4). 298–302. 8 indexed citations
15.
Wang, Di, Kai Yu, Yanjie Hu, et al.. (2011). A HYBRID ELECTRONIC NOSES' SYSTEM BASED ON MOS-SAW DETECTION UNITS INTENDED FOR LUNG CANCER DIAGNOSIS. Journal of Innovative Optical Health Sciences. 5(1). 1150006–1150006. 24 indexed citations
16.
Ying, Kejing, et al.. (2010). Effects of andrographolide on NF-κB signaling pathway in human lung adenocarcinoma A549 cells.. Zhongguo yaolixue yu dulixue zazhi. 24(2). 106–110. 1 indexed citations
17.
Hu, Yanjie, et al.. (2010). [Measurement of exhaled volatile organic compounds in lung cancer patients].. PubMed. 33(2). 104–8. 2 indexed citations
18.
Wang, Ping, et al.. (2008). Development of electronic nose for diagnosis of lung cancer at early atage. 588–591. 19 indexed citations
19.
Chen, Xing, et al.. (2007). A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Cancer. 110(4). 835–844. 204 indexed citations
20.
Ying, Kejing, et al.. (2005). [Pulmonary cryptococcosis: analysis of nine cases].. PubMed. 28(7). 464–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026